Ocular delivery systems for poorly soluble drugs: An in-vivo evaluation

International Journal of Pharmaceutics

Volumn 455, Issue 1-2, 2013, Pages 331-337

  Luschmann, C ^a   Herrmann, W ^b   Strauss O ^b,c   Luschmann, K ^d   Goepferich, A ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Pharma Stulln GmbH   (Germany)

Author keywords

Bioavailability; Biocompatibility; Cyclosporine A; Dry eye disease; In situ nanosuspension; Surfactant micelles

Indexed keywords

CYCLOSPORIN A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA DISEASE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG TISSUE LEVEL; DRUG TOLERABILITY; EMULSION; EYE EXAMINATION; EYE IRRITATION; IN VIVO STUDY; INFLAMMATORY DISEASE; INTRAOCULAR DRUG ADMINISTRATION; LIMIT OF QUANTITATION; MALE; MICELLE; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RABBIT;

BIOAVAILABILITY; BIOCOMPATIBILITY; CYCLOSPORINE A; DRY EYE DISEASE; IN-SITU NANOSUSPENSION; SURFACTANT MICELLES;

ADMINISTRATION, OPHTHALMIC; ANIMALS; CORNEA; CYCLOSPORINE; DRUG DELIVERY SYSTEMS; MALE; MICELLES; NANOPARTICLES; OPHTHALMIC SOLUTIONS; RABBITS; SOLUBILITY; SUSPENSIONS;

EID: 84884161868     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.07.002     Document Type: Article

References (26)

1. Ballantyne, B., 1993. Ophthalmic toxicology. In: Ballantyne, B., Marrs, T., Turner, P. (Eds.), General & Applied Toxicolog, vol. 1. The Macmillan Press, Basingstoke, pp. 567-593.
2. Daull, P., Lallemand, F., Philips, B., Lambert, G., Buggage, R., Garrigue, J.-S., 2013. Distribution of cyclosporine A in ocular tissues after topical administration of cyclosporine A cationic emulsions to pigmented rabbits. Cornea 32, 345-354.
3. Di Tommaso, C., Bourges, J.-L., Valamanesh, F., Trubitsyn, G., Torriglia, A., Jeanny, J.-C., Behar-Cohen, F., Gurny, R., Möller, M., 2012a. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies. Eur. J. Pharm. Biopharm. 81, 257-264.
4. Di Tommaso, C., Valamanesh, F., Miller, F., Furrer, P., Rodriguez-Aller, M., Behar-Cohen, F., Gurny, R., Moller, M., 2012b. A novel cyclosporin A aqueous formulation for dry eye treatment: in vitro and in vivo evaluation. Invest. Ophthalmol. Vis. Sci. 53, 2292-2299.
5. Donnenfeld, E., Pflugfelder, S.C., 2009. Topical ophthalmic cyclosporine: pharmacology and clinical uses. Surv. Ophthalmol. 54, 321-338.
6. El Tayar, N., Mark, A.E., Vallat, P., Brunne, R.M., Testa, B., van Gunsteren, W.F., 1993. Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations. J. Med. Chem. 36, 3757-3764. (Pubitemid 24006703)
7. Italia, J.L., Bhardwaj, V., Ravi Kumar, M., 2006. Disease, destination, dose and delivery aspects of ciclosporin: the state of the art. Drug Discov. Today 11, 846-854. (Pubitemid 44280030)
8. Kaswan, R.L., 1988. Intraocular penetration of topically applied cyclosporine. Transplant. Proc. 20 (Suppl. 2), 650-655.
9. Kulkarni, P., 2001. Review: uveitis and immunosuppressive drugs. J. Ocul. Pharmacol. Ther. 17, 181-187. (Pubitemid 32299082)
10. Kunert, K.S., Keane-Myers, A.M., Spurr-Michaud, S., Tisdale, A.S., Gipson, I.K., 2001. Alteration in goblet cell numbers and mucin gene expression in a mouse model of allergic conjunctivitis. Invest. Ophthalmol. Vis. Sci. 42, 2483-2489. (Pubitemid 32954852)
11. Kuwano, M., Ibuki, H., Morikawa, N., Ota, A., Kawashima, Y., 2002. Cyclosporine A formulation affects its ocular distribution in rabbits. Pharm. Res. 19, 108-111. (Pubitemid 34075115)
12. Lallemand, F., Felt-Baeyens, O., Besseghir, K., Behar-Cohen, F., Gurny, R., 2003. Cyclosporine A delivery to the eye: a pharmaceutical challenge. Eur. J. Pharm. Biopharm. 56, 307-318. (Pubitemid 37346503)
13. Lee, M., 2007. Apoptosis induced by polyethylenimine/DNA complex in polymer mediated gene delivery. Bull. Korean Chem. Soc. 28, 95-98. (Pubitemid 46168781)
14. Luschmann, et al., 2013a. Eur. J. Pharm. Sci., http://dx.doi.org/10.1016/ j.ejps.2013.07.002, in press.
15. Luschmann, et al., 2013b. Cornea (submitted for publication).
16. Mithani, S.D., Bakatselou, V., TenHoor, C.N., Dressman, J.B., 1996. Estimation of the increase in solubility of drugs as a function of bile salt concentration. Pharm. Res. 13, 163-167. (Pubitemid 26076314)
17. Mondon, K., Zeisser-Labouèbe, M., Gurny, R., Möller, M., 2011. Novel cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: a suitability study. Eur. J. Pharm. Biopharm. 77, 56-65.
18. OECD Guideline 405, 2001. Acute Eye Irritation/Corrosion. http://iccvam.niehs.nih.gov/SuppDocs/FedDocs/OECD/OECDtg405.pdf
19. Paiva, C.S.d., Pflugfelder, S.C., 2008. Rationale for anti-inflammatory therapy in dry eye syndrome. Arq. Bras. Oftalmol. 71 (Suppl.), 89-95.
20. Rao, S.N., 2010. Topical cyclosporine 0.05% for the prevention of dry eye disease progression. J. Ocul. Pharmacol. Ther. 26, 157-164.
21. Rodriguez-Aller, M., Kaufmann, B., Guillarme, D., Stella, C., Furrer, P., Rudaz, S., El Zaoui, I., Valamanesh, F., Di Tommaso, C., Behar-Cohen, F., Veuthey, J.-L., Gurny, R., 2012. In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease. Eur. J. Pharm. Biopharm. 80, 544-552.
22. Survase, S.A., Kagliwal, L.D., Annapure, U.S., Singhal, R.S., 2011. Cyclosporin A - a review on fermentative production, downstream processing and pharmacological applications. Biotechnol. Adv. 29, 418-435.
23. Utine, C.A., Stern, M., Akpek, E.K., 2010. Clinical review: topical ophthalmic use of cyclosporin A. Ocul. Immunol. Inflamm. 18, 352-361.
24. Vernillet, L., Lundh, R.L., Acezat-Mispelter, F., Goizel, C., Humbert, H., Pouliquen, Y., 1991. Ocular distribution of cyclosporin A (Sandimmun) following systemic and topical administration to rabbits. Eur. J. Drug Metab. Pharmacokinet. 3, 150-158.
25. Wiederholt, M., Koessendrup, D., Schulz, W., Hoffmann, F., 1986. Pharmacokinetics of topical cyclosporin A in the rabbit eye. Invest. Ophthalmol. Vis. Sci. 27, 519-524. (Pubitemid 16116297)
26. Yavuz, B., Bozdaǧ Pehlivan, S., Ünlü, N., 2012. An overview on dry eye treatment: approaches for cyclosporin A delivery. Sci. World J. 2012, 1-11.